top of page
Search

Harnessing the Power of Pyramid Energy Technology for Healing and Wellness

Updated: 2 days ago

DIVINE CODES JOURNEY - Integration and unfolding data! This is exciting for me to share. Hello, and welcome to our blog posts. Many will find the majority in my Instagram stories. But, also here on our site.



Study Summary: Pyramid Energy Boosts Antiviral Power of Medicine

Researchers tested how being inside a pyramid affects the virus-fighting ability of a medical drug called venoglobulin (a type of human antibody used to help the immune system fight viruses).


🔬 How the Study Was Done:

  • The drug venoglobulin was taken from France (a freeze-dried version for medical use).

  • It was tested on human skin cells grown in a lab.

  • Scientists used a dangerous mouse virus called EMC that usually damages or kills these cells.


💊 What They Tested:

They used two amounts (concentrations) of the drug:

  1. 50 μg/ml (strong)

  2. 0.5 μg/ml (100 times weaker)

They tested it in two ways:

  • One that was not exposed to the pyramid.

  • One that was kept inside a pyramid for a while.


🧫 What Normally Happens (No Pyramid):

  • The virus grows well in these cells and kills many of them.

  • The strong dose (50 μg/ml) helped protect the cells and reduced the virus significantly.

  • The weak dose (0.5 μg/ml) didn't protect the cells at all — it was too weak to help.


🔺 What Happened After the Pyramid:

  • The same drug, after being in the pyramid, had a much stronger virus-blocking effect.

  • Even the weak dose (0.5 μg/ml) now had the same power as the strong dose!

  • The drug continued to work even at much lower doses like 0.005 μg/ml and 0.00005 μg/ml.


🧠 What This Means:

  • The pyramid field seems to change something in the venoglobulin, making it much more powerful at stopping viruses.

  • After exposure to the pyramid, the drug worked regardless of how weak the dose was.

  • This suggests the pyramid amplified the antiviral properties of the drug in a way we don't fully understand yet.

 
 
 

Comments


bottom of page